Policy Studies: Eliminate Lymphatic Filariasis with Mass Drug Administration (MDA)

#Policy Evaluation-user research of MDA intervention in district health centers

The lymphatic filariasis elimination program is currently running in all provinces in Indonesia. Central Java becomes a big ten chronic case of Lymphatic Filariasis (LF) from 34 provinces in Indonesia. Started in 2015, Ministry of Health Republic Indonesia launched filariasis elimination by implementing preventive mass drug administration (MDA) or “POPM”. The minimum target 65% of the population in the district/city are given diethylcarbamazine citrate (DEC) and albendazole. The study aims to determine the constraints and problems encountered in the MDA implementation and the steps toward filariasis elimination. The method applied is a review of the scientific articles, policy inventories, discussions with experts and practitioners, as well as field data confirmations.

This study result describes of MDA coverage in Pekalongan Regency above of minimal coverage 65%, and around three years subsequently reaching 80%, the occurrence of side reactions after consuming drugs lower than 1% from all population target. The data reported that MDA implementation in Pekalongan District has fulfilled the target. However, the program evaluation is not only for tablet distribution, but also data of medication adherence. This study identified that MDA application should be supported by vector control and molecular examination for assessment of lymphatic filariasis vector capacity.

Full Report: http://download.garuda.kemdikbud.go.id/article.php?article=1699362&val=4885&title=PROGRAM%20NASIONAL%20UNTUK%20ELIMINASI%20FILARIASIS%20LIMFATIK%20STUDI%20KASUS%20DI%20KABUPATEN%20PEKALONGAN%20JAWA%20TENGAH